🔎 Trials Near Me

Home › Respiratory Syncytial Virus Infections

Respiratory Syncytial Virus Infections clinical trials recruiting in the U.S.

7 studies for Respiratory Syncytial Virus Infections are recruiting participants at sites across the United States.

Respiratory syncytial virus (RSV) causes cold-like symptoms in adults and healthy children but can cause serious problems in babies. Read more.

Cities with the most studies

By state

Recently updated studies

Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06817889

A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose

RecruitingPhase 3Healthy volunteers welcome
Ages 0 and older · All sexes · Updated Sep 24, 2026 · NCT06866405

A Study of BLB-201 RSV Vaccine in Infants and Children

RecruitingPhase 1/2Healthy volunteers welcome
6 Months – 5 Years · All sexes · Updated Sep 23, 2026 · NCT05655182

Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children

RecruitingPhase 3
3 Days – 2 Years · All sexes · Updated Feb 9, 2026 · NCT05026749

Real-World Effectiveness of Perinatal RSV Immunoprophylaxis

RecruitingObservational study
12 Months · All sexes · Updated Aug 14, 2025 · NCT06172660

Safety and Immunogenicity Study of Revaccination With SCB-1019T in Healthy Adults

RecruitingPhase 1Healthy volunteers welcome
Ages 60 to 85 · All sexes · Updated May 14, 2025 · NCT06843317

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.